
Number of publications published per year by Hoofnagle, Jay H.. (Source : PubMed)

Distribution of publications types for Hoofnagle, Jay H.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Ribavirin improves early responses to peginterferon through enhanced interferon signaling.
Gastroenterology
2010
Important Elements for the Diagnosis of Drug-Induced Liver Injury.
Clin. Gastroenterol. Hepatol.
2010
Clinical trial: low- and standard-dose peginterferon alfa-2a for chronic hepatitis C, genotype 2 or 3 - efficacy, tolerability, viral kinetics and cytokine response.
Aliment. Pharmacol. Ther.
2010
Increased caffeine consumption is associated with reduced hepatic fibrosis.
Hepatology
2010;51;1
Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner.
Gastroenterology
2010;138;1



Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression.
Clin. Gastroenterol. Hepatol.
2009;7;10



Decline in male sexual desire, function, and satisfaction during and after antiviral therapy for chronic hepatitis C.
Gastroenterology
2009;137;3


Evaluation of the patient with hepatitis B.
Hepatology
2009;49;5 Suppl
NIH consensus development conference: management of Hepatitis B. Introduction.
Hepatology
2009;49;5 Suppl


The hepatitis B research network.
Hepatology
2009;49;5 Suppl
[ See timeline ] [ See all publications ]
means that Hoofnagle, Jay H. has 80 papers cited a least 80 times - methodology
Liver Diseases Branch, National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.